Welcome to our dedicated page for NOVONIX SEC filings (Ticker: NVNXF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NOVONIX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NOVONIX's regulatory disclosures and financial reporting.
NOVONIX Ltd filed an initial insider ownership report for Chief Executive Officer Michael O'Kronley. The filing shows he holds performance rights that can be converted into 3,723,971 ordinary shares at an exercise price of $0.0000 per share, with these rights expiring on December 31, 2028. This is a holdings disclosure rather than a new buy or sell transaction.
NOVONIX Ltd director Robert J. Natter has filed a Form 3 reporting his existing ownership of the company’s ordinary shares. The filing shows 230,343 ordinary shares held directly. It also shows indirect ownership through trusts, with 1,365,888 ordinary shares held in a trust where he is trustee and 1,298,758 ordinary shares held in a trust where his spouse is trustee. These entries are reported as holdings, not as new market transactions, and provide a baseline view of his beneficial ownership in NOVONIX.
NOVONIX Ltd director Ronald C. Edmonds has filed an initial Form 3 disclosing his ownership in the company. The filing reports that he directly holds 416,342 ordinary shares as of March 16, 2026. This establishes his starting equity position as a reporting insider under SEC rules.
NOVONIX Ltd director files initial ownership report with no transactions
NOVONIX Ltd director Vaidyanathan Suresh has filed a Form 3, which is an initial statement of beneficial ownership for company insiders. The filing does not report any equity transactions or derivative exercises, and shows no derivative positions in the derivative summary section.
NOVONIX Ltd director Jean Oelwang filed an initial Form 3 disclosing current holdings in the company. The filing reports direct ownership of 309,508 ordinary shares of NOVONIX as of the reported date, with no associated purchase, sale, or derivative transactions described.
NOVONIX Ltd director Burrow Sharan has filed an initial ownership report showing a significant personal stake in the company. The Form 3 indicates direct beneficial ownership of 215,739 ordinary shares. This filing establishes Sharan’s starting equity position as a director and does not reflect any specific recent share purchase or sale.
NOVONIX Ltd director Liveris Nicholas has reported his direct ownership of the company’s ordinary shares. As of 2026-03-16, he is shown as holding 459,090 ordinary shares directly. The filing does not show any new purchase or sale activity, only the reported ownership position.
NOVONIX Ltd director Tony Bellas filed an initial statement of beneficial ownership of ordinary shares. The filing reports 95,744 ordinary shares held directly. It also reports additional ordinary share holdings indirectly through corporations controlled by him, including 230,246 shares and 2,398,145 shares, reflecting his total reported equity stake as of the filing date.
Novonix Limited filed a Form 6-K reporting a change in director shareholdings via an attached ASX Appendix 3Y. The notice covers director Nicholas Liveris, whose interest is recorded as a direct holding following an on-market trade. After this change, he holds 459,090 ordinary shares in Novonix.
Novonix Limited has reported the issue of 5,517,712 unquoted NVXAD performance rights on 13 March 2026 under its employee incentive scheme. These rights are in an existing, unquoted ASX class and rank equally with other securities in that class.
Key management personnel received a significant portion, including Robert Long with 2,069,142 performance rights, and both Kimberly Heimert and Dwayne Johnson with 1,724,285 each. Following this issue, Novonix has 861,365,155 NVX ordinary fully paid shares quoted on ASX and 28,735,426 NVXAD performance rights on issue. The issue was made under Listing Rule 7.2 exception 13, so no separate security holder approval was required.